Multimodal therapy for stage-II breast cancer.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D009367:Neoplasm Staging
D000970:Antineoplastic Agents